+PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

01/01/2009

VAT status

Active

Bankruptcy proceedings

No proceedings

+PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated because the company delayed submission of financial statements.

Incorporation date

24/11/2008

Share capital

50,000.00 PLN

Primary activity

Wholesale of pharmaceutical goods (46.46.Z - PKD 2007)

Representatives

Representatives rights

JEŻELI ZARZĄD SPÓŁKI JEST JEDNOOSOBOWY, CZŁONEK ZARZĄDU REPREZENTUJE SPÓŁKĘ SAMODZIELNIE. W PRZYPADKU GDY ZARZĄD SPÓŁKI JEST WIELOOSOBOWY, DO REPREZENTOWANIA SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ŁĄCZNIE Z PROKURENTEM.

Representatives

No representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
-	-

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

2,990,271

Net Profit (zł)

2,990,271

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2021
26,972,217
3,114,372
2,420,544
0.45
5.38
8.97
11,734,924
2,781,202
0
35,710

2022
31,676,530
4,307,703
3,207,698
0.46
8.40
10.13
14,056,989
1,988,937
0
18,224

2023
36,699,136
3,915,969
2,990,271
0.49
6.24
8.15
17,000,298
3,415,214
0
3,980

2023
36,699,136
3,915,969
2,990,271
0.49
6.24
8.15
17,000,298
3,415,214
0
3,980

Turnover (zł)

2023

Turnover (zł)

36,699,136 zł16 % *

Profit before tax (zł)

3,915,969 zł-9 % *

Net Profit (zł)

2,990,271 zł-7 % *

Working capital requirement (%)

0.49 6.52 % *

Liquidity ratio

6.24 -25.71 % *

Net profitability (%)

8.15 %-19.55 % *

Equity (zł)

17,000,298 zł21 % *

Current liabilities (zł)

3,415,214 zł72 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

3,980 zł-78 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

+PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
21/10/2025	OD 01.01.2024 DO 31.12.2024
31/07/2024	OD 01.01.2022 DO 31.12.2022
31/07/2024	OD 01.01.2023 DO 31.12.2023
30/01/2023	OD 01.01.2019 DO 31.12.2019
30/01/2023	OD 01.01.2020 DO 31.12.2020